Unicycive resubmits NDA for OLC, new PDUFA date in 1H 2026, expected 30 days post resubmission.
The anticipated PDUFA date for the drug submission is projected to fall within the first half of 2026, approximately 30 days subsequent to the resubmission of the New Drug Application (NDA).
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments